Zhihong Wang

38PUBLICATIONS
74CO-AUTHORS
PharmacogenomicsPsychopharmacologyHuman biophysicsMolecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Sep 29, 2026
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

|Jul 30, 2026
KCNJ5-Dependent 68Ga-Pentixafor PET/CT in Primary Aldosteronism Surgery.

|Jul 22, 2026
Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.

|Jun 22, 2026
HRS-7535, an oral small-molecule GLP-1 receptor agonist, in Chinese adults with obesity without diabetes: a randomized, double-blind, placebo-controlled phase 2 trial.

|May 01, 2026
TPD52 inhibits aldosterone synthesis through suppression of CAMKK2 signaling.

|Mar 17, 2026
Efficacy of Renin Angiotensin Aldosterone System Inhibitors on Cardiovascular Outcomes in Hypertensive Population: A Network Meta-analysis of Randomized Controlled Trials.

Yueming Jiang, Jinbo Hu, Xiaoyan Yi

Pageof 7

Frequent Collaborators

16 joint publications

Jinbo Hu

14 joint publications

Shumin Yang

7 joint publications

Jun Yang

5 joint publications

Zhihong Wang